Biofrontera Inc.
BFRINASDAQHealthcareMedical - Pharmaceuticals
Latest quote
$1.48
$0.00 · 0.00%
BFRI company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
70
Undervalued
Momentum
68
Gaining
Sentiment
52
Mixed
Risk resilience
51
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteBiofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Hermann Lübbert
- Listed since
- Oct 29, 2021
- Employees
- 89
Market position
- Volume
- 446.34K
- 1.37× average
- Average volume
- 324.72K
- Average daily volume
- Market cap
- 18.95M USD
- Beta
- 0.8
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 5.57M USD
- P/E (TTM)
- -2.47×
- P/B (TTM)
- 3.21×
- P/S (TTM)
- 0.41×
- EV / EBITDA
- -0.61×
- Earnings yield
- -181.72%
- Free cash flow yield
- -230.48%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 84.45%
- Operating margin
- -9.45%
- Net margin
- -13.78%
- Return on equity
- -100.53%
- Return on assets
- -36.89%
- Return on invested capital
- -53.81%
Financial health
- Debt / equity
- 1.26×
- Current ratio
- 1.52×
Earnings
- EPS beat rate
- 45%
- 5 beats, 6 misses, 0 met estimates
- Average EPS surprise
- -85.88%
- 11 comparable reports
- Latest EPS result
- -0.05
- Estimate -0.11 · Beat by 52.38%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
BFRI peers
ETFs holding BFRI
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research BFRIresearch.disclaimer